LifeTech Argues To High Court: Patent Law Was Wrongly Broadened Abroad
(September 15, 2016, 3:14 PM EDT) -- WASHINGTON, D.C. — In a $52 million patent case over DNA tests, the Federal Circuit U.S. Court of Appeals erred when it extended U.S. patent law’s reach to allow for infringement damages if a component of a patented invention originates from the United States and is combined with others overseas, Life Technologies Corp. (LifeTech) argues in a Sept. 1 petitioner brief to the U.S. Supreme Court (Life Technologies Corp. v. Promega Corp., No. 14-1538, U.S. Sup.).